Literature DB >> 26407660

Plasma amino acid profiles in healthy East Asian subpopulations living in Japan.

Hidehiro Nakamura1, Natsumi Nishikata1, Nobuhiro Kawai1, Akira Imaizumi1, Hiroshi Miyano1, Maiko Mori1, Hiroshi Yamamoto1, Yasushi Noguchi2.   

Abstract

OBJECTIVES: Profiles of plasma free amino acids (PFAAs) have been utilized as biomarkers to detect various diseases. However, few studies have investigated whether ethnicity or specific subpopulations within East Asia influence PFAA concentrations.
METHODS: A total of 95 healthy volunteers living in Japan, including 31 Japanese individuals, 36 Korean individuals and 28 Chinese individuals, were enrolled. Participants' PFAA levels were measured by high-performance liquid chromatography mass spectrometry, and the effects of factors such as sex, age, body mass index (BMI) and subpopulation on PFAA profiles were analyzed.
RESULTS: With the exception of glutamine and α-aminobutyric acid, there were no significant differences among the three examined subpopulations with respect to either the means or the distributions of PFAA concentrations. A multiple regression analysis revealed that most of the PFAA concentrations were significantly related to sex. Ornithine concentrations, glutamate concentrations, and glutamine and α-aminobutyric acid concentrations were significantly associated with age, BMI, and Chinese subpopulation, respectively.
CONCLUSION: The study results indicate that the contributions of subpopulation within East Asia to PFAA profiles are small, particularly relative to the contributions provided by sex.
© 2015 The Authors American Journal of Human Biology Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26407660      PMCID: PMC5054856          DOI: 10.1002/ajhb.22787

Source DB:  PubMed          Journal:  Am J Hum Biol        ISSN: 1042-0533            Impact factor:   1.937


Amino acids (AAs) play important roles as both basic metabolites and physiological regulators. Although AA metabolism is strictly regulated in healthy individuals, reports have indicated that certain diseases influence plasma free amino acid (PFAA) profiles (Holm et al., 1999; Hong et al., 1998; Miyagi et al., 2011; Felig et al., 1970). Based on these PFAA characteristics, “AminoIndex Technology,” which can evaluate specific health conditions and disease possibilities by analyzing PFAA status, has recently been described (Miyagi et al., 2011; Okamoto 2011). PFAA homeostasis is primarily maintained by the balance among the endogenous synthesis of nonessential AAs, the degradation of AAs, and the synthesis and breakdown of proteins. Because these reactions are performed by various enzymes, PFAA profiles may be influenced by genetic variations in enzymes involved in AA metabolism. In fact, a prior genome‐wide association study (GWAS) of the human metabolome indicated that certain AAs are associated with genetic loci encoding either AA transporters or enzymes involved in serine (Ser) biosynthesis (Rhee et al., 2013). It has been reported that the frequency of single nucleotide polymorphisms in certain enzymes involved in drug metabolism is associated with ethnicity (Man et al., 2010). Genetic variations among three major East Asian subpopulations (Japanese, Korean and Chinese) have also been reported with respect to enzymes, including the CYP19*3 variant (Man et al., 2010), although variations are much smaller than between Europeans and Africans. However, there have been no reports regarding the genetic heterogeneity of enzymes involved in AA metabolism, and few studies have described the relationship between PFAA profiles and either ethnicity or subpopulations. In this study, we compared the PFAA concentrations of healthy Japanese, Korean, and Chinese individuals living in Japan and investigated how subpopulation, as well as age, sex, and body mass index (BMI), affected PFAA profiles.

MATERIALS AND METHODS

Ethics statement

This study was conducted in accordance with the Declaration of Helsinki, and experimental protocols were approved by the ethics committee of Ajinomoto Co., Inc. All subjects provided written informed consent for their inclusion before participating in the study. All data were analyzed anonymously throughout the study.

Enrollment

A total of 95 healthy volunteers, including 31 Japanese individuals, 36 Korean individuals and 28 Chinese individuals (86 percent of whom were Han Chinese) were recruited for this study. Each participant's subpopulation was determined using a questionnaire that verified the Japanese, Korean or Chinese backgrounds of both of the participant's parents. All subjects had been living in Japan for at least one year. Information about diet was based on a 3‐month recall interview. The frequency of food intake from their home countries (e.g., Korean food for Korean and Chinese food for Chinese) was investigated by choosing from “daily,” 4–6 times a week, “1–3 times a week,” “2–3 times month,” once a month or less often,″ and “never.” Fifty‐eight percent of Korean and 50% of Chinese consume their local food more than 4–6 times a week. The exclusion criteria of taking medication, pregnancy, mental disorders and cancer were applied at the beginning of the study.

Quantification of plasma AA concentrations

Blood samples (5 ml) were collected from forearm veins in the morning following overnight fasting into tubes containing ethylenediaminetetraacetic acid. These samples were immediately placed on ice. Plasma was prepared via centrifugation at 2,010 g and 4°C for 15 min and stored at −80°C until needed for analysis. Subsequently, plasma samples were deproteinized with acetonitrile at a final concentration of 80%. The samples were then subjected to precolumn derivatization followed by high‐performance liquid chromatography (HPLC)‐electrospray ionization (ESI)‐mass spectrometry (MS) for AA quantification, which was performed as previously described (Shimbo et al., 2009a; Shimbo et al., 2009b; Yoshida et al., 2015). The following 21 AAs were quantified: alanine (Ala), alpha‐aminobutyric acid (α‐ABA), arginine (Arg), asparagine (Asn), citrulline (Cit), glutamate (Glu), glutamine (Gln), glycine (Gly), histidine (His), isoleucine (Ile), leucine (Leu), lysine (Lys), methionine (Met), ornithine (Orn), phenylalanine (Phe), proline (Pro), serine (Ser), threonine (Thr), tryptophan (Trp), tyrosine (Tyr), and valine (Val).

Statistical analysis

Study data are presented as means ± standard deviation (SD). Statistical and multivariate analyses were performed using the JMP 9.0.0 program (SAS Institute Inc., NC). To assess differences among the three subpopulations, Tukey's test was performed following a one‐way analysis of variance (ANOVA). Levene's test was performed to assess the homogeneity of variances. Multiple linear regression (MLR) was used to evaluate the contributions of background factors (sex, age, BMI or subpopulation) to PFAA concentrations. P < 0.05 was established as the level of significance following Bonferroni multiple comparison tests.

RESULTS

Table 1 presents the characteristics of the Japanese, Korean, and Chinese subjects enrolled in this study. The sex ratios of subjects in these three subpopulations did not differ. The mean age of the Korean participants was significantly lower than the mean age of the Japanese and Chinese participants. The mean BMI of the Chinese subjects was significantly higher than the mean BMI of the Japanese subjects.
Table 1

Plasma AA concentrations in three major East Asian subpopulations

JapaneseKoreanChinese P‐value by ANOVA P‐value by Levene's test
N (Male/Female)31 (16/15)36 (19/17)28 (13/15)NS
Age (years)46.5 ± 7.4a 37.2 ± 6.7b 45.1 ± 11.0a <0.00010.0177
BMI (kg·m−2)21.0 ± 1.9b 21.5 ± 2.4a,b 22.7 ± 2.7a 0.02360.0930
Essential amino acids (μmol./L)
Val 213.6 ± 59.5 (134.3–368.1) 207.4 ± 40.4 (118.3–312.0) 224.7 ± 38.5 (156.4–282.5)0.34190.0711
Ile 61.1 ± 19.4 (38.0–115.3) 61.7 ± 14.9 (33.6–104.2) 63.6 ± 15.2 (42.8–96.7)0.83550.3469
Leu 118.6 ± 34.6 (70.1–206.0) 116.9 ± 27.8 (67.7–169.3) 127.2 ± 24.6 (85.2–177.1)0.35100.4097
His 85.8 ± 10.6 (65.5–106.0) 83.2 ± 9.2 (63.9–99.2) 82.4 ± 9.2 (68.1–98.0)0.36690.8350
Phe 57.5 ± 10.1 (45.5–89.5) 55.4 ± 9.6 (40.0–78.2) 59.0 ± 9.2 (46.3–88.8)0.32370.6421
Trp 54.9 ± 11.8 (36.3–82.1) 56.8 ± 9.8 (36.1–83.5) 55.3 ± 9.6 (34.0–74.2)0.73900.4979
Met 26.8 ± 5.8 (18.5–44.5) 27.7 ± 5.9 (18.5–40.6) 25.0 ± 6.5 (13.6–47.3)0.19770.8616
Thr 133.7 ± 33.1 (81.3–235.5) 138.0 ± 29.4 (74.0–238.6) 119.2 ± 32.4 (62.2–192.2)0.05580.5712
Lys 173.1 ± 31.4 (113.0–255.2) 181.9 ± 28.4 (131.8–249.7) 181.2 ± 38.1 (102.6–276.7)0.49160.6991
Nonessential amino acids (μmol./L)
Ser 113.3 ± 23.8 (62.1–179.1) 124.3 ± 20.8 (82.4–166.5) 116.2 ± 22.8 (80.3–161.1)0.11980.6604
Gly 246.4 ± 58.9 (95.3–397.7) 240.1 ± 53.4 (119.1–381.0) 229.0 ± 40.4 (166.1–326.0)0.43110.3460
Ala 384.6 ± 97.1 (250.1–595.6) 370.7 ± 94.0 (241.7–671.3) 372.1 ± 108.9 (196.2–681.5)0.82920.7391
Tyr 59.8 ± 16.6 (38.3–116.9) 59.4 ± 13.6 (31.6–90.9) 62.5 ± 13.4 (40.5–107.2)0.66420.7540
Glu 26.3 ± 12.0 (10.1–50.3) 24.1 ± 11.9 (8.3–64.9) 32.7 ± 20.1 (11.7–86.7)0.06690.0351
Pro 146.2 ± 48.3 (67.1–271.2) 159.8 ± 49.7 (97.2–272.7) 150.5 ± 60.1 (73.2–348.2)0.55730.6801
Gln 617.9 ± 65.1a (474.8–743.8) 578.2 ± 62.9a,b (402.4–706.4) 554.0 ± 70.7b (437.7–700.0) 0.0013* 0.6794
Cit 31.1 ± 6.2 (17.5–41.7) 29.6 ± 7.0 (19.6–46.5) 30.2 ± 7.3 (16.5–42.9)0.66990.5085
Arg 96.1 ± 20.6 (53.6–138.6) 101.0 ± 16.8 (69.5–135.8) 101.9 ± 25.9 (59.6–151.2)0.50680.0103
Orn 47.9 ± 15.2 (17.8–83.3) 48.6 ± 10.6 (26.6–79.7) 50.0 ± 14.9 (24.2–83.5)0.82560.1480
Asn 48.8 ± 5.6 (38.0–65.1) 48.2 ± 7.8 (34.2–71.5) 48.6 ± 9.7 (33.9–71.8)0.95340.0591
α‐ABA 14.5 ± 3.6b (9.4–22.9) 17.6 ± 5.4a,b (10.1–35.0) 20.4 ± 6.5a (9.0–36.0) 0.0003* 0.0355

Data are presented as means ± SD (range). The chi‐squared test was used to test for differences in sex distributions. Levene's test was performed to assess the homogeneity of variances. Significant differences among the three groups were determined by one‐way ANOVA followed by Tukey's test and are presented in bold. Different characters indicate significant differences (P<0.002). *A significance level of P < 0.002 was established (a Bonferroni‐corrected threshold).

Plasma AA concentrations in three major East Asian subpopulations Data are presented as means ± SD (range). The chi‐squared test was used to test for differences in sex distributions. Levene's test was performed to assess the homogeneity of variances. Significant differences among the three groups were determined by one‐way ANOVA followed by Tukey's test and are presented in bold. Different characters indicate significant differences (P<0.002). *A significance level of P < 0.002 was established (a Bonferroni‐corrected threshold). The concentrations of 21 PFAAs in the examined subpopulations were compared (Table 1). Gln and α‐ABA concentrations were significantly lower and higher, respectively, in the Chinese subpopulation than in the Japanese subpopulation. No significant differences among subpopulations were observed with respect to the concentrations of the remaining 19 PFAAs. Additionally, there were no significant differences among the three subpopulations with respect to the variances in PFAA concentrations. To investigate the contributions of sex, age, BMI, and subpopulation to PFAA concentrations, MLR analysis was applied (Table 2). The results of this analysis indicated that most of the PFAA concentrations were strongly related to sex. Age, BMI, and Chinese subpopulation significantly affected Orn, Glu, and Gln and α‐ABA concentrations, respectively. The Korean subpopulation factor had no effect on PFAA profiles.
Table 2

The influences of sex, age, BMI, and subpopulation on PFAA concentrations

Factors
SexAgeBMIKoreanChinese
Essential amino acids
Val <0.0001* 0.98640.20510.47480.4115
Ile <0.0001* 0.84510.18480.94900.6007
Leu <0.0001* 0.44620.04440.41060.3622
His0.01090.89810.39760.24750.1454
Phe <0.0001* 0.33710.21660.53220.6071
Trp <0.0001* 0.70860.81860.58380.7506
Met <0.0001* 0.72310.18070.53830.1467
Thr0.27300.46160.63830.89660.0757
Lys0.00620.22300.07290.15640.5267
Nonessential amino acids
Ser0.49350.98500.36560.07040.4461
Gly0.12270.34630.02890.89630.6650
Ala0.01530.07720.16380.93060.4906
Tyr 0.0011* 0.31090.02140.93310.7926
Glu 0.0007* 0.5952 0.0004* 0.45550.3265
Pro 0.0003* 0.18510.59430.13090.6889
Gln0.02310.02930.73930.1703 0.0006*
Cit0.00500.03840.33570.89630.9601
Arg0.03050.44270.14680.28040.4517
Orn <0.0001* <0.0001* 0.59650.04650.3004
Asn0.05150.45890.47260.92580.7981
α‐ABA0.17200.68700.09420.0335 0.0004*

Multiple linear regression was applied to estimate the effects of sex, age, BMI and subpopulation, and the resulting P values are presented (*a significance level of P < 0.002; Bonferroni‐corrected threshold). Significant differences are presented in bold.

The influences of sex, age, BMI, and subpopulation on PFAA concentrations Multiple linear regression was applied to estimate the effects of sex, age, BMI and subpopulation, and the resulting P values are presented (*a significance level of P < 0.002; Bonferroni‐corrected threshold). Significant differences are presented in bold.

DISCUSSION

In the current study, there were no significant differences among subpopulations with respect to the distributions and mean levels of all examined PFAAs except for Gln and α‐ABA. Chinese subpopulation significantly influenced plasma concentrations of Gln and α‐ABA, even after the effects of background characteristics such as sex, age and BMI were eliminated. However, the concentrations of these AAs in most of the Chinese subjects were within reference intervals for Japanese subjects (431.0–691.6 μM for Gln and 11.2–31.6 μM for α‐ABA) (Yamamoto et al., 2015), suggesting that the PFAA profiles of Korean and Chinese individuals living in Japan do not greatly differ from those of Japanese individuals. Certain prior studies have examined the influence of ethnicity on PFAA profiles. Lawton et al. (2008) measured plasma metabolites in healthy Europeans, African‐Americans and Hispanics; their findings demonstrated that among these populations, ethnicity exerts only limited effects on concentrations of PFAAs. Another group measured PFAA concentrations in Greenlanders and Danes and reported that residence exerted the strongest influence on PFAA concentrations; ethnicity and diet had little to no effect on these concentrations, although ethnicity was weakly related to the plasma concentrations of Glu, His, Cit, and Arg (Pedersen et al., 2006). These data are consistent with our results, which indicate that differences among East Asian subpopulations do not provide large contributions to determining PFAA concentrations in healthy subjects. Additional studies are needed to clarify the effects of residence and dietary habits on PFAA profiles (e.g., Korean and Chinese subjects living in Japan for less than one year). MLR analysis demonstrated that PFAA profiles, particularly with respect to essential AAs, were more strongly related to sex than to age, BMI or subpopulation. Our previous study also found that sex is a more influential factor for PFAA profiles than age or BMI (Yamamoto et al., 2015). In addition, reports have indicated that PFAA levels are strongly correlated with visceral fat area and insulin‐related parameters but not with subcutaneous fat area (Nakamura et al., 2014; Yamakado et al., 2012). Furthermore, the ingestion of a low‐protein diet leads to decreased PFAA levels (Fujita et al., 1978). These results suggest that PFAA levels may be more strongly influenced by sex, physiological conditions or dietary habits than by genetic factors. In conclusion, we have demonstrated that there is little to no difference among the PFAA profiles of Japanese, Korean and Chinese individuals living in Japan, although this is a preliminary study and needs confirmation with larger numbers of subjects. These results suggest that it may be feasible to clinically utilize PFAA profiles for the detection of diseases such as cancer or metabolic syndrome, independent of differences among the three East Asian subpopulations. Further investigations are needed to confirm whether PFAA profile changes associated with these diseases and physiological conditions are similar among these subpopulations.
  15 in total

Review 1.  Amino acid metabolism in liver disease.

Authors:  E Holm; O Sedlaczek; E Grips
Journal:  Curr Opin Clin Nutr Metab Care       Date:  1999-01       Impact factor: 4.294

2.  Plasma amino acids in Greenlanders and Danes: influence of seasons, residence, ethnicity, and diet.

Authors:  Erling B Pedersen; Marit E Jørgensen; Michael B Pedersen; Charlotte Siggaard; Tina B Sørensen; Gert Mulvad; Jens C Hansen; Anne M Torstensen; Ole Aagaard; Henning Skjoldborg
Journal:  Am J Hum Biol       Date:  2006-01       Impact factor: 1.937

3.  Validation of an analytical method for human plasma free amino acids by high-performance liquid chromatography ionization mass spectrometry using automated precolumn derivatization.

Authors:  Hiroo Yoshida; Kazuhiro Kondo; Hiroyuki Yamamoto; Naoko Kageyama; Shin-Ichi Ozawa; Kazutaka Shimbo; Takahiko Muramatsu; Akira Imaizumi; Toshimi Mizukoshi; Junichi Masuda; Daisuke Nakayama; Yoshihiro Hayakawa; Kyoko Watanabe; Kazuo Mukaibatake; Hiroshi Miyano
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-06-26       Impact factor: 3.205

4.  Plasma amino acid profile is associated with visceral fat accumulation in obese Japanese subjects.

Authors:  M Yamakado; T Tanaka; K Nagao; Y Ishizaka; T Mitushima; M Tani; A Toda; E Toda; M Okada; H Miyano; H Yamamoto
Journal:  Clin Obes       Date:  2012-05-22

5.  Plasma amino acid levels in diabetic ketoacidosis.

Authors:  P Felig; E Marliss; J L Ohman; C F Cahill
Journal:  Diabetes       Date:  1970-10       Impact factor: 9.461

6.  A genome-wide association study of the human metabolome in a community-based cohort.

Authors:  Eugene P Rhee; Jennifer E Ho; Ming-Huei Chen; Dongxiao Shen; Susan Cheng; Martin G Larson; Anahita Ghorbani; Xu Shi; Iiro T Helenius; Christopher J O'Donnell; Amanda L Souza; Amy Deik; Kerry A Pierce; Kevin Bullock; Geoffrey A Walford; Ramachandran S Vasan; Jose C Florez; Clary Clish; J-R Joanna Yeh; Thomas J Wang; Robert E Gerszten
Journal:  Cell Metab       Date:  2013-07-02       Impact factor: 27.287

7.  The relationship between plasma homocysteine and amino acid concentrations in patients with end-stage renal disease.

Authors:  S Y Hong; D H Yang; S K Chang
Journal:  J Ren Nutr       Date:  1998-01       Impact factor: 3.655

8.  Precolumn derivatization reagents for high-speed analysis of amines and amino acids in biological fluid using liquid chromatography/electrospray ionization tandem mass spectrometry.

Authors:  Kazutaka Shimbo; Takashi Oonuki; Akihisa Yahashi; Kazuo Hirayama; Hiroshi Miyano
Journal:  Rapid Commun Mass Spectrom       Date:  2009-05       Impact factor: 2.419

9.  Multifunctional and highly sensitive precolumn reagents for amino acids in liquid chromatography/tandem mass spectrometry.

Authors:  Kazutaka Shimbo; Akihisa Yahashi; Kazuo Hirayama; Masakazu Nakazawa; Hiroshi Miyano
Journal:  Anal Chem       Date:  2009-07-01       Impact factor: 6.986

10.  Plasma amino acid profiles are associated with insulin, C-peptide and adiponectin levels in type 2 diabetic patients.

Authors:  H Nakamura; H Jinzu; K Nagao; Y Noguchi; N Shimba; H Miyano; T Watanabe; K Iseki
Journal:  Nutr Diabetes       Date:  2014-09-01       Impact factor: 5.097

View more
  3 in total

1.  Increased plasma proline concentrations are associated with sarcopenia in the elderly.

Authors:  Kenji Toyoshima; Marie Nakamura; Yusuke Adachi; Akira Imaizumi; Tomomi Hakamada; Yasuko Abe; Eiji Kaneko; Soiciro Takahashi; Kentaro Shimokado
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

2.  Interictal plasma glutamate levels are elevated in individuals with episodic and chronic migraine.

Authors:  Chae Gyu Park; Min Kyung Chu
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

3.  Alteration in plasma free amino acid levels and its association with gout.

Authors:  M H Mahbub; Natsu Yamaguchi; Hidekazu Takahashi; Ryosuke Hase; Hiroki Amano; Mikiko Kobayashi-Miura; Hideyuki Kanda; Yasuyuki Fujita; Hiroshi Yamamoto; Mai Yamamoto; Shinya Kikuchi; Atsuko Ikeda; Naoko Kageyama; Mina Nakamura; Yasutaka Ishimaru; Hiroshi Sunagawa; Tsuyoshi Tanabe
Journal:  Environ Health Prev Med       Date:  2017-03-16       Impact factor: 3.674

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.